GPGI, CMPO DEADLINE NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages GPGI, Inc. f/k/a CompoSecure, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 14 Deadline in Securities Class Action - GPGI, CMPO

Rosen Law Firm reminded investors of the September 14, 2026 lead plaintiff deadline for a class period covering GPGI (formerly CompoSecure) Class A common stock purchases from Nov. 3, 2025 through May 6, 2026. The firm states eligible purchasers may seek compensation on a contingency basis with no out-of-pocket fees. While this is legal process-focused, it can add headline risk for the stock tied to potential shareholder claims.

Analysis

This is more an overhang than a standalone earnings event: the market usually discounts these reminders only if they point to a disclosure problem large enough to affect guidance, financing, or strategic optionality. Absent a regulator or auditor stepping in, the typical path is a legal reserve, higher D&O friction, and a modest multiple cap rather than a fundamental impairment. The immediate risk window is the next 2-6 weeks around plaintiff deadline chatter; the real catalyst is not the deadline itself but whether the filed complaint adds a hard operational allegation that forces management commentary.

Second-order, the main loser is the equity story, not the customer base. Litigation overhang tends to widen the bid/ask for small-cap industrial/payment-adjacent names and can pressure any planned capital return or M&A currency narrative if investors demand a bigger governance discount. The contrarian view is that class-action reminders are often noisy: if the alleged issue is already reflected in disclosed risk factors and there is no SEC follow-on, the stock can recover once the complaint is parsed and insurance coverage is confirmed. What would falsify the bearish read is a clean motion-to-dismiss path, no amendment, and a contained settlement range that leaves leverage and buyback capacity intact.

Key Decisions for Investors

• Do not add fresh long exposure to CMPO/GPGI until the complaint is filed and the alleged misstatement is testable; the event is low-information but can still compress the multiple 5-10% if headline risk re-accelerates.
• If already long, hedge into the lead-plaintiff deadline with a small, short-dated put spread on CMPO (30-60 days) rather than outright selling; the thesis only pays if the legal overhang widens, so keep premium outlay modest.
• Watch for D&O insurance disclosure and any reserve increase over the next 1-2 quarters; if legal expense guidance rises or free-cash-flow conversion is revised down, reduce/exit immediately.
• Contrarian alert: if the stock sells off on the deadline but no new facts emerge, fade the move after the first filing pulse; these reminders often create temporary dislocations that mean-revert within 1-3 weeks.
• If a cleaner, non-litigation peer trades at a similar valuation, prefer that name over CMPO/GPGI for new capital until the 1-3 month litigation path is visible.